INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Observational study / 2013

Elevated plasma vitamin B12 levels were linked to an increased risk of subsequently diagnosed cancer, especially during the first year of follow-up.

Researchers analyzed 333,667 Danish patients referred for cobalamin (Cbl) measurement without prevalent cancer or Cbl treatment (1998-2009) to assess cancer incidence. Six percent had Cbl levels ≥601 pmol/L. Cancer risk increased with higher Cbl levels and peaked during the first year of follow-up (Cbl 601-800 pmol/L: SIR = 3.44, 95% CI = 3.14 to 3.76; Cbl >800 pmol/L: SIR = 6.27, 95% CI = 5.70 to 6.88; both P < .001). Elevated risks were particularly notable for hematological and smoking- and alcohol-related cancers.

Shows an association, not proof of cause and effect.

Study type
Population-based cohort study
Who was studied
333,667 persons in Northern Denmark referred for Cbl measurement, without prevalent cancer and not receiving Cbl treatment
What was measured
Cancer risk (standardized incidence ratios [SIRs]) by plasma vitamin B12 (cobalamin) levels

THE PAPER

Elevated plasma vitamin B12 levels as a marker for cancer: a population-based cohort study.

Arendt JF, Pedersen L, Nexo E, Sørensen HT. J Natl Cancer Inst, 2013.

PubMed 24249744 ↗DOI 10.1093/jnci/djt315 ↗

CancerNutrients & adequacy

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.